Physician profile
Jaydutt B Patel
NPI 1508960683
$13,224.83
in general payments reported to CMS, 2019-2025
19 companies · $711 in 2025
The $711 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,089 · 2020: $1,069 · 2021: $1,159 · 2022: $204 · 2023: $477 · 2024: $3,516 · 2025: $711.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,527 · Travel and Lodging: $2,177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,527.05 |
| Travel and Lodging | $2,177.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $5,750.04 | 2019 | |
| Abbott Laboratories | $2,493.84 | 2019-2025 | Aveir, Ensite, Gallant |
| Medtronic, INC. | $2,087.91 | 2024 | Micra |
| Philips North America LLC | $922.33 | 2021-2025 | Extended Holter |
| Biosense Webster, INC. | $899.69 | 2021-2025 | Carto 3, Octaray Mapping Catheter, Qdot Micro |
| Boston Scientific Corporation | $510.54 | 2019-2025 | Emblem Mri S-Icd, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Atricure, INC. | $212.18 | 2024-2025 | Synergy Ablation System |
| Cardiva Medical, INC. | $94.53 | 2020-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Amgen INC. | $47.57 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $39.64 | 2019-2023 | |
| Kestra Medical Technology Services, INC. | $32.69 | 2024 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.05 | 2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $20.88 | 2024 | Camzyos |
| Janssen Pharmaceuticals, INC | $17.87 | 2024 | Xarelto |
| Stryker Corporation | $15.54 | 2025 | N/A |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $15.52 | 2023 | Surgiflo Hemostatic Matrix, Vistaseal, Surgicel Nu-Knit |
| Sanofi-Aventis U.S. LLC | $15.08 | 2024 | |
| Cordis US Corp. | $14.62 | 2025 | Mynx Control Venous |
| Astrazeneca Pharmaceuticals LP | $13.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaydutt Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.